Thomas Watkins's Net Worth
$13.9 Million
Who is Thomas Watkins?
Thomas Watkins has an estimated net worth of $13.9 Million. This is based on reported shares across multiple companies, which include HORIZON PHARMA, INC., Vanda Pharmaceuticals Inc., and HUMAN GENOME SCIENCES INC.
SEC CIK
Thomas Watkins's CIK is 0001307935
Past Insider Trading and Trends
2014 was Thomas Watkins's most active year for acquiring shares with 8 total transactions. Thomas Watkins's most active month to acquire stocks was the month of May. 2023 was Thomas Watkins's most active year for disposing of shares, totalling 10 transactions. Thomas Watkins's most active month to dispose stocks was the month of June. 2023 saw Thomas Watkins paying a total of $1,106,550.01 for 89,252 shares, this is the most they've acquired in one year. In 2012 Thomas Watkins cashed out on 3,678,544.24 shares for a total of $50,039,505.42, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HORIZON PHARMA, INC. No price found
InvestorThomas Watkins used to own units in Common Stock and Ordinary Shares but no longer holds any shares there. In the year 2014 Thomas Watkins filed a total of 23 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -176.40K |
$116.50 | -$20,550,600.00 |
0
|
Oct 6
| |||
Form 4
| +279.23% | 81.32K |
$13.61 | $1,106,550.01 | 110.45K |
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 4
| +15.52% | 3.91K |
—
|
—
| 29.12K |
Apr 28
| |||
Form 4
| +5.95% | 4.22K |
—
|
—
| 75.16K |
Apr 28 - Apr 29
| |||
Form 4
| +18.55% | 11.1K |
—
|
—
| 70.94K |
Apr 29 - Apr 30
| |||
Form 4
| +34.62% | 15.39K |
—
|
—
| 59.84K |
Apr 30 - May 2
| |||
Form 4
| +33.63% | 11.19K |
$26.54 | -$109,663.28 | 44.45K |
May 2 - May 3
| |||
Form 4
| +73.16% | 14.05K |
—
|
—
| 33.27K |
May 3
| |||
Form 4
| +265.37% | 13.95K |
—
|
—
| 19.21K |
May 3
| |||
Form 4
|
∞
| 5.26K |
—
|
—
| 5.26K |
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 3
| |||
Form 4
|
∞
| 10K |
$31.32 | $313,240.00 | 10K |
Aug 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4/A
|
∞
| 6K |
—
|
—
| 6K |
Sep 19
| |||
Form 4/A
| -100.00% | -6.00K |
—
|
—
|
0
|
Sep 19
| |||
Form 4
|
∞
| 6K |
$9.76 | $58,560.00 | 6K |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Vanda Pharmaceuticals Inc. (VNDA) Snapshot price: $5.12
InvestorThomas Watkins owns 63,064 units of Common Stock which is worth $322,887.68. From 2006 to 2022 Thomas Watkins acquired a total of 120,000 shares in Vanda Pharmaceuticals Inc. at a cost of $683,300.00, Thomas also disposed a total of 56,936 shares of Vanda Pharmaceuticals Inc. equalling to $901,090.11.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +15.70% | 8.56K |
$7.03 | -$1,528.78 | 63.06K |
Jun 2
| |||
Form 4
| +10.10% | 5K |
—
|
—
| 54.51K |
Jun 10
| |||
Form 4
| +22.77% | 9.18K |
$12.83 | -$1,205.83 | 49.51K |
Feb 16
| |||
Form 4
| +14.16% | 5K |
—
|
—
| 40.32K |
Jun 11
| |||
Form 4
| +17.74% | 5.32K |
$9.44 | -$585.50 | 35.32K |
May 29
| |||
Form 4
| +20.00% | 5K |
—
|
—
| 30K |
Jun 13
| |||
Form 4
| +25.00% | 5K |
—
|
—
| 25K |
Jun 13
| |||
Form 4
| +300.00% | 15K |
$4.98 | $74,700.00 | 20K |
May 3
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
$13.53 | -$289,170.00 |
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
HUMAN GENOME SCIENCES INC No price found
Chief Executive OfficerThomas Watkins used to own units in Common Stock but no longer holds any shares there.acquired a total of 177,469.12 shares in HUMAN GENOME SCIENCES INC at a cost of $839,803.50, Thomas also disposed a total of 343,544.24 shares of HUMAN GENOME SCIENCES INC equalling to $2,515,755.42.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -100.00% | -166.08K |
$11.96 | -$106,685.88 |
0
|
Nov 2 - Jul 30
| |||
Form 4
| -100.00% | -166.08K |
$14.25 | -$2,366,570.46 |
0
|
Jul 25 - Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
| +1,000.00% | 60K |
$24.16 | $1,449,600.00 | 66K |
Jan 5
| |||
Form 4
| +0.48% | 801.28 |
$19.64 | $15,737.14 | 166.08K |
Jul 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| +0.61% | 1K |
$1.80 | $1,800.00 | 165.27K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| +155.58% | 100K |
$2.02 | $202,000.00 | 164.27K |
Nov 12
| |||
Form 4
| +3.68% | 2.28K |
$4.49 | $10,241.78 | 64.27K |
Jul 1
| |||
Form 4
| +47.63% | 20K |
$4.93 | $98,700.00 | 61.99K |
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
| +4.98% | 1.99K |
$7.59 | $15,125.50 | 41.99K |
Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
∞
| 6K |
$12.05 | $72,300.00 | 6K |
Nov 10
| |||
Form 4
| +300.00% | 30K |
$11.14 | $334,200.00 | 40K |
Sep 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
∞
| 10K |
$11.95 | $119,500.00 | 10K |
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |